Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people experience some side effects in their first week on Mounjaro, and the majority are gastrointestinal — nausea is the most common, affecting a significant proportion of people starting tirzepatide at 2.5mg. Symptoms typically peak in the first few days after injection and ease as your body adjusts over the following week or two. Mounjaro is a prescription-only medicine, so a qualified prescriber will discuss these effects with you before treatment begins. Knowing what to expect (and what falls outside the normal range) makes those early days considerably easier to navigate.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That question sits at the heart of the first week. Tirzepatide works partly by slowing how quickly food leaves your stomach, a mechanism that reduces appetite but also explains why your digestive system can protest in the early days. The NHS patient information for tirzepatide lists nausea, vomiting, diarrhoea, constipation, stomach discomfort, burping and reflux as common reactions. Fatigue and headache appear too, though less consistently.
Most of these settle within a week to a fortnight as your body acclimatises. The starting dose of 2.5mg exists precisely to ease this process, it gives your system time to adjust before the dose is reviewed. Many people find the first two to three days post-injection are the most noticeable, with symptoms fading towards the end of the week.
Injection-site reactions (redness, mild swelling or itching where you inject) are also normal. Rotating sites between your abdomen, thigh and upper arm with each weekly dose helps. If you're unsure what to expect on the day you take your very first dose, the detail on what the first day typically feels like may be useful reading before you inject.
Small changes to eating habits make a real difference during this period. Eating slowly, choosing smaller portions and avoiding heavy, fatty meals reduces the likelihood of nausea worsening after you eat. Staying well hydrated matters too, particularly if loose stools or vomiting occur, since dehydration compounds the discomfort and, in more severe cases, can affect your kidneys.
Timing your injection can also help. Some people find injecting in the evening means the peak of any nausea happens overnight rather than disrupting a working day. Others prefer the morning and find the effect manageable. There's no single right answer; it's worth trying the timing that fits your routine and discussing it with your prescriber if you're struggling. A question our prescribers hear fairly often is whether skipping meals helps, it doesn't reliably, and maintaining protein intake is particularly important while on tirzepatide.
If your week-one experience leaves you wondering whether symptoms are improving as expected, the week-two picture gives a useful sense of what progression typically looks like.
Most side effects in week one are uncomfortable, not dangerous. The distinction worth holding onto: persistent symptoms that feel disproportionate to the descriptions above, or that are getting worse rather than easing, deserve a call to your prescriber or GP rather than a wait-and-see approach.
Specific signs that need prompt attention include severe stomach pain (especially if it radiates through to your back) with or without vomiting. The MHRA's Drug Safety Update in January 2026 confirmed acute pancreatitis as an infrequent but serious known risk with GLP-1 receptor agonist medicines; this is the symptom pattern to act on quickly. Signs of a serious allergic reaction (difficulty breathing, swelling of the face or throat, a rapid heartbeat) also require emergency help immediately.
Dehydration from repeated vomiting or diarrhoea is worth taking seriously too. If you cannot keep fluids down for an extended period, contact your prescriber or 111 rather than waiting for it to resolve on its own. For a fuller overview of the side-effect profile beyond week one, the complete Mounjaro side effects guide covers the longer picture, and if you want to understand the five most commonly reported Mounjaro side effects in more detail, that breakdown is worth reading alongside it. Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme.
Knowing that the first week is often the hardest can be genuinely reassuring. It is also the reason that clinical review before starting matters so much. A prescriber who knows your medical history can flag whether any pre-existing condition (a history of pancreatitis, certain gastrointestinal conditions or specific medicines) warrants extra caution or changes the risk-benefit picture. If you are approaching the end of your first week and want to know what typically happens next, reading about what side effects to expect in week three can help you plan ahead and spot any changes worth discussing with your prescriber.
Mounjaro is a prescription-only medicine; the NICE appraisal of tirzepatide sets out the clinical criteria under which it is recommended, and a prescriber works through that framework with you individually. At nume, that review is done by a GPhC-registered Independent Prescriber who reads your consultation the same day, a real clinician assessing your specific circumstances, not an automated system. Side effects, your starting dose and what to do if you're struggling are all part of that conversation. If you'd like to explore whether Mounjaro is suitable for you, our prescribers are the right starting point; you can begin with a free consultation.
For broader context on how tirzepatide works and what the treatment involves, the Mounjaro overview covers the full picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.